Chapter

The Advantages of SARMs Over Anabolic Steroids
SARMs have the advantage of not carrying the stigma associated with anabolic steroids, making them a more politically acceptable option. It is possible to mimic the benefits of fasting pre-chemotherapy with exogenous ketones without increasing systemic IGF one levels.
Clips
Dosages of 100-200mg a week of IGF-1 do not increase hormones that cause cancer growth, however, dosages of 300-600mg of testosterone per week can increase systemic IGF-1 levels which can have a protein sparing effect.
37:44 - 39:42 (01:58)
Summary
Dosages of 100-200mg a week of IGF-1 do not increase hormones that cause cancer growth, however, dosages of 300-600mg of testosterone per week can increase systemic IGF-1 levels which can have a protein sparing effect.
ChapterThe Advantages of SARMs Over Anabolic Steroids
Episode#117: Dom D'Agostino on Fasting, Ketosis, and The End of Cancer
PodcastThe Tim Ferriss Show
The primary advantage of SARMs is that they do not have the same stigma as anabolic steroids, making them more politically acceptable.
39:42 - 45:02 (05:20)
Summary
The primary advantage of SARMs is that they do not have the same stigma as anabolic steroids, making them more politically acceptable. Meanwhile, exogenous ketones may mimic the benefits of fasting pre-chemotherapy.
ChapterThe Advantages of SARMs Over Anabolic Steroids
Episode#117: Dom D'Agostino on Fasting, Ketosis, and The End of Cancer
PodcastThe Tim Ferriss Show
The body regulates its endogenous ketone production by releasing insulin when levels get too high, signaling the liver to turn down or off hepatic ketogenesis.
45:02 - 48:15 (03:13)
Summary
The body regulates its endogenous ketone production by releasing insulin when levels get too high, signaling the liver to turn down or off hepatic ketogenesis. Ketone levels over five millimolar are rare, with typical levels staying between three to five millimolar, except for in the case of glucose transporter type one deficiency syndrome which sees higher levels.